What is Semi-Daonil 2.5mg?
Semi-Daonil is a trusted brand of Glibenclamide (also known as glyburide), an oral blood-sugar-lowering medication. Manufactured by Sanofi, it belongs to the second-generation sulfonylurea class of drugs. It is specifically formulated to help manage blood glucose levels in adults living with Type 2 Diabetes Mellitus.
The "Semi" in its name refers to the 2.5mg strength, which is half the dose of the standard 5mg Daonil tablet, allowing for precise dosage adjustments by your healthcare provider.
How Semi-Daonil Works
Semi-Daonil works by stimulating the beta cells in the pancreas to produce and release more insulin. Insulin is the hormone responsible for moving sugar from the bloodstream into the body's cells for energy. By increasing insulin production, Semi-Daonil helps lower elevated blood sugar levels.
Dosage and Administration
Semi-Daonil is typically taken once daily. For the best results and to minimize the risk of low blood sugar (hypoglycemia), it should be taken immediately before or during your first main meal of the day (usually breakfast).
- Follow your doctor's instructions: Never change your dose without professional medical advice.
- Consistency is key: Take it at the same time every day.
- Bulk Pack: This 800-tablet presentation is a hospital-sized bulk pack, containing 80 strips of 10 tablets each, ideal for long-term management or clinical dispensing.
Important Safety Information
- Hypoglycemia: Because Glibenclamide is a potent medication, it can cause low blood sugar. Symptoms include sweating, shakiness, and confusion. Always keep a fast-acting sugar source (like glucose tabs or a sugary drink) nearby.
- Sanofi Quality: While Sanofi has transitioned its distribution model in Nigeria, Semi-Daonil remains a premium choice for diabetes management.
For personalized advice or concerns about side effects, you can speak with a GoMed pharmacist today.